Loading…
Achieve Life Sciences, Inc. is projected to rise to $5.52 by 2027, a +15% move from its current price of $4.78. ACHV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.57 | $4.78 | $5.01 | +0.09% |
| May 30 | $4.49 | $4.79 | $5.11 | +0.19% |
| May 31 | $4.43 | $4.79 | $5.19 | +0.28% |
| Jun 1 | $4.38 | $4.80 | $5.25 | +0.38% |
| Jun 2 | $4.34 | $4.80 | $5.32 | +0.48% |
| Jun 3 | $4.30 | $4.81 | $5.37 | +0.57% |
| Jun 4 | $4.27 | $4.81 | $5.43 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.27 | $4.81 | $5.43 | +0.67% |
| Week 2 | $4.09 | $4.84 | $5.74 | +1.34% |
| Week 3 | $3.96 | $4.88 | $6.00 | +2.01% |
| Week 4 | $3.86 | $4.91 | $6.24 | +2.69% |
| Week 5 | $3.78 | $4.94 | $6.46 | +3.37% |
| Week 6 | $3.71 | $4.97 | $6.67 | +4.06% |
| Week 7 | $3.64 | $5.01 | $6.88 | +4.76% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Achieve Life Sciences, Inc. (ACHV) is a healthcare company that develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. It is described as a late-stage pharmaceutical company focused on this therapeutic approach. The company is headquartered in Bothell, Washington.
Achieve Life Sciences, Inc. trades at $4.69 and has a market capitalization of $481.47M. Its market ranking is 3062. These figures place the stock within a broad global healthcare equity universe.
A major floor 51.2% below — a decisive break under it would weaken the trend.
The nearest floor, 25.7% below — buyers have tended to step in here.
The nearest ceiling, 25.3% above — a clean break opens room to run.
A major ceiling 50.9% above — clearing it would confirm fresh momentum.
Key ACHV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACHV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.64 | Buy | $4.72 | Buy |
| MA 10 | $4.95 | Sell | $4.80 | Sell |
| MA 20 | $4.89 | Sell | $4.76 | Buy |
| MA 50 | $4.15 | Buy | $4.48 | Buy |
| MA 100 | $4.41 | Buy | $4.34 | Buy |
| MA 200 | $4.12 | Buy | $4.15 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.01 | Neutral |
| Stoch RSI (14) | 18.02 | Buy |
| CCI (20) | -15.57 | Neutral |
| Williams %R (14) | -78.57 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -8.25 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 21.43 | Neutral |
| TRIX (15) | 0.87 | Buy |
| Awesome (5,34) | 0.10 | Buy |
| Ultimate (7,14,28) | 39.69 | Neutral |
| Momentum (10) | -1.21 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 4.56 | Buy |
| ADX (14) | 17.57 | Neutral |
| ATR (14) | 0.21 | Info |
The near-term technical picture shows bullish sentiment with RSI14 at 50. The stock's price has traded close to the moving averages, with SMA50 at $4.13 and SMA200 at $4.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.65 | $4.78 | $6.73 | 0% | Neutral | |
| $4.10 | $5.52 | $8.01 | +15% | Neutral | |
| $4.79 | $6.77 | $10.38 | +42% | Bullish | |
| $5.75 | $8.48 | $13.55 | +77% | Bullish | |
| $6.10 | $9.34 | $15.46 | +95% | Bullish | |
| $6.57 | $10.42 | $17.78 | +118% | Bullish | |
| $6.19 | $10.15 | $17.81 | +112% | Bullish | |
| $5.87 | $9.93 | $17.85 | +108% | Bullish | |
| $6.14 | $10.70 | $19.67 | +124% | Bullish | |
| $6.60 | $11.85 | $22.24 | +148% | Bullish | |
| $8.67 | $17.94 | $36.67 | +275% | Bullish | |
| $17.84 | $39.64 | $91.18 | +729% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.65 | $4.78 | $5.70 | +0.00% |
| June 2026 | $4.35 | $5.18 | $6.38 | +8.45% |
| July 2026 | $4.31 | $5.21 | $6.55 | +0.54% |
| August 2026 | $4.10 | $5.01 | $6.40 | -3.93% |
| September 2026 | $4.16 | $5.13 | $6.65 | +2.51% |
| October 2026 | $4.25 | $5.29 | $6.94 | +3.13% |
| November 2026 | $4.06 | $5.09 | $6.75 | -3.83% |
| December 2026 | $3.98 | $5.03 | $6.73 | -1.26% |
Click any year to see its month-by-month ACHV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ACHV could reach as high as $6.73, with a base case around $4.78 and support toward $2.65 — roughly 0% from $4.78. A consolidation phase looks the most probable path here.
Expect ACHV to range from $4.10 to $8.01 through 2027. The $5.52 average target implies a +15% move from current prices. That is up +15% on the projected 2026 average. Price action looks broadly range-bound.
The ACHV price prediction for 2028 points to an average of $6.77 (low $4.79, high $10.38) — a potential gain of +42% on today's $4.78. Buyers look set to stay in control over this stretch.
In 2029, ACHV is projected to trade between $5.75 and $13.55, averaging $8.48 — a potential gain of +77% from today's $4.78. That is up +25% on the projected 2028 average. Momentum favours further upside here.
Achieve Life Sciences, Inc.'s 2030 outlook centres on $9.34, within a $6.10 to $15.46 range. That is up +10% on the projected 2029 average. That marks a +95% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ACHV could reach as high as $17.78, with a base case around $10.42 and support toward $6.57 — roughly +118% from $4.78. Momentum favours further upside here.
Expect ACHV to range from $6.19 to $17.81 through 2032. The $10.15 average target implies a +112% move from current prices. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The ACHV price prediction for 2033 points to an average of $9.93 (low $5.87, high $17.85) — a potential gain of +108% on today's $4.78. Momentum favours further upside here.
In 2034, ACHV is projected to trade between $6.14 and $19.67, averaging $10.70 — a potential gain of +124% from today's $4.78. That is up +8% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Achieve Life Sciences, Inc.'s 2035 outlook centres on $11.85, within a $6.60 to $22.24 range. That is up +11% on the projected 2034 average. That marks a +148% change versus current levels. Momentum favours further upside here.
By 2040, ACHV could reach as high as $36.67, with a base case around $17.94 and support toward $8.67 — roughly +275% from $4.78. Buyers look set to stay in control over this stretch.
Expect ACHV to range from $17.84 to $91.18 through 2050. The $39.64 average target implies a +729% move from current prices. That is up +121% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ACHV today (≈ 209.205021 ACHV) could be worth
$8,293.51
+$7,293.51 (+729%) by 2050 · US Dollar
Based on the average projected ACHV price of $39.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACHVwould be worth at today's price.
$1,000 invested in ACHV on May 27, 2025 (≈ 316.455688 ACHV) would be worth
$1,512.66
+$512.66 (+51.3%) today · 1.51× · US Dollar
Based on a ACHV entry price of $3.16 vs. today's $4.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.57 | $1,045.95 | +4.6% |
| 1 month ago | $3.96 | $1,207.07 | +20.7% |
| 3 months ago | $4.73 | $1,010.57 | +1.1% |
| 6 months ago | $4.87 | $981.52 | -1.8% |
| 1 year ago | $3.16 | $1,512.66 | +51.3% |
| All time (5.0y) ago | $8.21 | $582.22 | -41.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACHV forecast.
Our base-case forecast reaches $9.60 around 2031.
Implied market cap at $9.60: $985.53M
The year-by-year forecast shows a gradual rise in average price from 2026 through 2050, with a notable bullish trajectory from 2028 onward. In 2026 the avg is $4.69 with ROI 0 and sentiment Neutral, then 2027 avg $5.45 (ROI 16.3) Neutral, 2028 avg $6.57 (ROI 40) Bullish, 2029 avg $8.39 (ROI 78.8) Bullish. By 2030 the avg is $9.23 (ROI 96.8) Bullish, 2031 avg $10.17 (ROI 116.8) Bullish, 2032 avg $10.00 (ROI 113.3) Bullish, 2033 avg $9.67 (ROI 106.3) Bullish, 2034 avg $10.35 (ROI 120.6) Bullish, 2035 avg $11.71 (ROI 149.6) Bullish.
The forecast continues bullish into 2040 with avg $17.33 (ROI 269.6) Bullish and reaches an avg of $39.13 (ROI 734.4) by 2050, also Bullish. This path implies strong upside potential over the longer horizon while noting early years show modest or neutral momentum.
Tap a question to reveal the answer.
2030 avg is $9.23, with min $5.96 and max $15.44; ROI 96.8; sentiment Bullish.
Forecasts show a bullish trajectory from 2028 onward, with 2050 avg $39.13 and ROI 734.4. Early years show neutral sentiment, and outcomes are estimates, not guarantees.
Yes. The 2034 avg is $10.35 and the 2035 avg is $11.71, indicating the potential to exceed $10 by that period.
Current price is $4.69 and market cap is $481.47M.
2040 avg is $17.33 with min $8.17 and max $35.92; ROI 269.6; sentiment Bullish.
Achieve Life Sciences, Inc. Community Discussion
0Share your Achieve Life Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.